Clinical trial Recruiting at 1 site Observational Ages 30 to 40

Understanding cardiovascular risks in young adults born to hypertensive pregnancies

Official title: Cardiovascular Longitudinal the Avon Longitudinal Study of Parents and Children (ALSPAC) Research Investigations Following Hypertensive Pregnancy in Young Adulthood

Run by University of Oxford · NCT05683093 · Data updated 2026-11-12

This study is looking at the heart health of young adults in their 20s and 30s who were born to mothers with high blood pressure during pregnancy to see if it affects their risk of heart problems later on.

Quick facts

Study typeObservational
Ages30 Years to 40 Years
SexAll
Enrollment200 (estimated)
SponsorUniversity of Oxford
Academic / other
Locations1 site (Oxford, Oxfordshire)
StatusRecruiting
StartedNovember 17, 2022
Main results expectedMarch 1, 2026
Study endsJanuary 31, 2027
Registry record updatedJanuary 12, 2023
Trial IDNCT05683093 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 30 to 40 who were born to hypertensive pregnancies and previously participated in the ALSPAC study.

Probably not a fit

Patients who are currently pregnant, lactating, or have significant chronic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the cardiovascular health of individuals in their 20s and 30s who were born to mothers with hypertension during pregnancy. It seeks to identify the long-term effects of hypertensive pregnancies on blood pressure and heart disease risk in these individuals. By analyzing changes in the heart, blood vessels, and brain, the study hopes to uncover patterns that could predict future cardiovascular issues. The findings may lead to new prevention strategies for early onset heart and blood vessel diseases in this population.

Why it matters

Potential benefit: If successful, this study could lead to improved prevention strategies for cardiovascular diseases in young adults who were born to hypertensive pregnancies.

How similar studies have gone: Previous studies have indicated that understanding the long-term effects of hypertensive pregnancies can reveal significant cardiovascular risks, suggesting this approach has merit.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant is willing and able to give informed consent for participation in the study
* Male or female, aged 30 to 40 years at time of enrolment
* Participant previously took part in the ALSPAC study
* Able (in the investigator's opinion) and willing to comply with all study requirements
* Adequate understanding of verbal and written English

Exclusion Criteria:

* Pregnant or lactating when they are due to attend for study visit 1
* Less than six months postpartum
* Planning to donate blood within two weeks prior to study visit 1
* Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study
* Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status

For exclusion of MRI component only:

* Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study

Where it's running

  • University of Oxford
    Oxford, Oxfordshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.